棕榈股份(002431) - 2024 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2024 was ¥940,003,740.74, an increase of 8.26% compared to ¥868,278,664.95 in the same period last year[5]. - Total operating revenue for Q1 2024 was CNY 940,003,740.74, an increase of 8.25% compared to CNY 868,278,664.95 in Q1 2023[27]. - Total operating costs for Q1 2024 were CNY 1,051,918,921.45, up 10.53% from CNY 951,759,021.89 in the same period last year[27]. - Net loss for Q1 2024 was CNY 103,427,032.89, compared to a net loss of CNY 94,238,349.98 in Q1 2023, reflecting a decline of 9.83%[28]. - The total comprehensive loss for Q1 2024 was CNY 103,397,014.54, compared to a loss of CNY 97,081,934.23 in the same quarter last year[28]. - The net profit attributable to shareholders was -¥102,773,328.45, representing a decrease of 16.20% from -¥88,448,457.20 year-over-year[5]. Cash Flow - The net cash flow from operating activities decreased by 66.87% to ¥92,675,508.69, down from ¥279,701,484.46 in the previous year[5]. - Cash flow from operating activities decreased to CNY 913,997,754.65 in Q1 2024 from CNY 1,428,654,507.52 in Q1 2023, a decline of 36.00%[29]. - Total cash inflow from financing activities was ¥2,271,668,750.00, while cash outflow was ¥2,250,134,783.24, resulting in a net cash flow of ¥21,533,966.76[30]. - The total cash and cash equivalents at the end of Q1 2024 amounted to ¥215,175,758.61, compared to ¥710,602,284.54 at the end of Q1 2023, indicating a significant decrease[30]. - Cash inflow from operating activities totaled ¥1,013,824,097.54, while cash outflow was ¥921,148,588.85, leading to a positive cash flow from operations[30]. - The company reported cash inflow from investment activities of ¥8,160.66, with cash outflow totaling ¥37,265,928.98, resulting in a negative cash flow of ¥37,257,768.32[30]. - The company received ¥721,500,000.00 in cash from borrowings during Q1 2024, down from ¥1,727,500,000.00 in Q1 2023[30]. - The cash received from other financing activities was ¥1,550,000,000.00, compared to ¥1,124,271,261.88 in the previous year[30]. - The company paid ¥889,500,000.00 in cash for debt repayment in Q1 2024, a decrease from ¥1,770,000,000.00 in Q1 2023[30]. Assets and Liabilities - Total assets at the end of the reporting period were ¥19,153,206,413.73, a 1.40% increase from ¥18,889,028,106.06 at the end of the previous year[5]. - The total assets increased to CNY 19,153,206,413.73 in Q1 2024 from CNY 18,889,028,106.06 in Q1 2023, marking a growth of 1.40%[27]. - The company's total liabilities increased significantly, with long-term borrowings rising by 368.63% compared to the previous year[11]. - The total liabilities rose to CNY 15,768,984,064.19, an increase of 2.41% from CNY 15,397,784,007.85 in the previous year[27]. - The company's equity attributable to shareholders decreased by 3.32% to ¥3,178,112,072.00 from ¥3,287,394,015.10 at the end of the previous year[5]. - The company's total equity attributable to shareholders decreased to CNY 3,178,112,072.00 from CNY 3,287,394,015.10, a reduction of 3.33%[27]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 76,340[18]. - The top 10 shareholders hold a combined 45.06% of the shares, with 河南省豫资保障房管理运营有限公司 holding 28.72%[18]. - The company has repurchased a total of 2,881,800 shares, accounting for 0.16% of the total share capital, with a total transaction amount of 6,538,633 RMB[22]. - The company plans to repurchase shares with a total amount not less than 50 million RMB and not exceeding 100 million RMB, at a price not exceeding 3.48 RMB per share[21]. Other Financial Activities - The company reported a 90.77% increase in credit impairment losses, primarily due to increased provisions for bad debts on accounts receivable[13]. - Investment income surged by 1181.73% year-over-year, attributed to the disposal of subsidiary equity[14]. - The company transferred 100% equity of four wholly-owned subsidiaries for a total transaction amount of 201.1153 million RMB to its controlling shareholder[23]. - Research and development expenses for Q1 2024 were CNY 30,027,180.99, slightly up from CNY 28,572,869.90 in Q1 2023, indicating a focus on innovation[27]. Accounting and Auditing - The company did not undergo an audit for the Q1 2024 report[31]. - The new accounting standards were first implemented in 2024, affecting the financial statements[31].